Published in J Behav Med on October 07, 2012
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems. Expert Opin Drug Metab Toxicol (2014) 0.89
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders. Addict Sci Clin Pract (2015) 0.88
High-intensity cannabis use associated with lower plasma human immunodeficiency virus-1 RNA viral load among recently infected people who use injection drugs. Drug Alcohol Rev (2014) 0.82
Antiretroviral treatment adherence as a mediating factor between psychosocial variables and HIV viral load. J Assoc Nurses AIDS Care (2014) 0.78
High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting. AIDS Behav (2015) 0.77
Anxiety sensitivity in relation to sleep quality among HIV-infected individuals. J Assoc Nurses AIDS Care (2014) 0.75
High-intensity cannabis use and HIV clinical outcomes among HIV-positive people who use illicit drugs in Vancouver, Canada. Int J Drug Policy (2017) 0.75
Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults. AIDS Res Treat (2016) 0.75
Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013. AIDS Behav (2016) 0.75
The impact of marijuana use on memory in HIV-infected patients: a comprehensive review of the HIV and marijuana literatures. Curr Drug Abuse Rev (2016) 0.75
Prevalence and correlates of marijuana use among HIV-seropositive and seronegative men in the Multicenter AIDS Cohort Study (MACS), 1984-2013. Am J Drug Alcohol Abuse (2016) 0.75
The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi. AIDS Care (2016) 0.75
HIV-infected individuals who use alcohol and other drugs, and virologic suppression. AIDS Care (2017) 0.75
Identifying HIV care enrollees at-risk for cannabis use disorder. AIDS Care (2016) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
Adherence to medication. N Engl J Med (2005) 39.77
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One (2010) 10.39
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS (2001) 8.89
Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav (2006) 8.11
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J Acquir Immune Defic Syndr (2006) 5.87
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS (2002) 5.21
Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol (2002) 4.52
Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J Acquir Immune Defic Syndr (2000) 4.03
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med (2003) 3.81
Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population. Drug Alcohol Depend (1997) 3.61
Review of the validity and significance of cannabis withdrawal syndrome. Am J Psychiatry (2004) 3.26
Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr (2000) 2.94
Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med (2005) 2.83
Adherence-resistance relationships to combination HIV antiretroviral therapy. Curr HIV/AIDS Rep (2007) 2.68
Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology (2007) 2.55
Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (2001) 2.51
Adherence to HAART regimens. AIDS Patient Care STDS (2003) 2.27
Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr (2004) 2.03
Better adherence with once-daily antiretroviral regimens: a meta-analysis. Clin Infect Dis (2009) 1.94
The Marijuana Check-up: promoting change in ambivalent marijuana users. Addiction (2007) 1.83
The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr (2004) 1.82
Predictors of antiretroviral adherence. AIDS Care (2004) 1.72
Predictors of medication adherence among HIV-infected youth. Psychol Health Med (2005) 1.68
Marijuana use motives: concurrent relations to frequency of past 30-day use and anxiety sensitivity among young adult marijuana smokers. Addict Behav (2006) 1.64
An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict (2009) 1.54
Nonclinical panic attack history and smoking cessation: an initial examination. Addict Behav (2004) 1.52
Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage (2005) 1.51
Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res (2008) 1.47
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr (2007) 1.44
Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr (2004) 1.33
The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse (1998) 1.24
Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr (2005) 1.21
Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care STDS (2004) 1.20
Alcohol and adherence to antiretroviral medications: interactive toxicity beliefs among people living with HIV. J Assoc Nurses AIDS Care (2012) 1.19
Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder. J Psychiatr Res (2008) 1.14
Associations between substance use, sexual risk taking and HIV treatment adherence among homeless people living with HIV. AIDS Care (2009) 1.10
Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci (2004) 1.09
Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care (2007) 1.01
Marijuana as therapy for people living with HIV/AIDS: social and health aspects. AIDS Care (2007) 0.94
Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res (2009) 0.90
Predictors for non-adherence to antiretroviral therapy. Sex Health (2004) 0.89
HIV patient insight on adhering to medication: a qualitative analysis. AIDS Care (2008) 0.87
Cognitive executive functioning in relation to HIV medication adherence among gay, bisexual, and other men who have sex with men. AIDS Behav (2007) 0.85
Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy. AIDS Behav (2011) 0.85
Plasma HIV-1 RNA levels during antiretroviral therapy: how low is low enough? Clin Infect Dis (2012) 0.83
Vulnerability and non-adherence to antiretroviral therapy among HIV patients, Minas Gerais State, Brazil. Cad Saude Publica (2008) 0.80
Evaluation of laboratory markers of progression of HIV disease to death. Rev Soc Bras Med Trop (2011) 0.75
The role of drug use in a conceptual model of intimate partner violence in men and women arrested for domestic violence. Psychol Addict Behav (2008) 1.93
Pilot test of seeking safety treatment with male veterans. Psychiatr Serv (2007) 1.46
Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Drug Alcohol Depend (2005) 1.38
Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain (2014) 1.33
Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence. Psychiatr Serv (2012) 1.33
What do patients do with unused opioid medications? Clin J Pain (2014) 1.28
Predictors of retention in methadone programs: a signal detection analysis. Drug Alcohol Depend (2005) 1.24
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse (2013) 1.24
Prevalence of cannabis use disorder diagnoses among veterans in 2002, 2008, and 2009. Psychol Serv (2012) 1.24
Interaction between smoking rate and anxiety sensitivity: relation to anticipatory anxiety and panic-relevant avoidance among daily smokers. J Anxiety Disord (2006) 1.12
Validation of a brief screen for Post-Traumatic Stress Disorder with substance use disorder patients. Addict Behav (2006) 1.04
Reasons for under-use of prescribed opioid medications by patients in pain. Pain Med (2010) 1.00
Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers. Psychol Serv (2013) 0.95
Measurement of adherence to clinical practice guidelines for opioid therapy for chronic pain. Transl Behav Med (2012) 0.94
Implementation of buprenorphine in the Veterans Health Administration: results of the first 3 years. Drug Alcohol Depend (2007) 0.94
Seeking Safety treatment for male veterans with a substance use disorder and post-traumatic stress disorder symptomatology. Addiction (2012) 0.89
Identifying neck and back pain in administrative data: defining the right cohort. Spine (Phila Pa 1976) (2012) 0.89
Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of pre- and postsynaptic receptor distributions. Brain Res (2002) 0.88
The effect of stress on craving for methadone depends on the timing of last methadone dose. Behav Res Ther (2008) 0.87
Routine opt-out HIV screening: more evidence in support of alternative approaches? Sex Transm Dis (2014) 0.86
How are substance use disorders addressed in VA psychiatric and primary care settings? Results of a national survey. Psychiatr Serv (2007) 0.85
Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? Am J Drug Alcohol Abuse (2013) 0.84
Predicting response to cognitive-behavioral therapy in a sample of HIV-positive patients with chronic pain. J Behav Med (2009) 0.83
The cost of concordance with opiate substitution treatment guidelines. J Subst Abuse Treat (2010) 0.83
Pain anxiety, acceptance, and outcomes among individuals with HIV and chronic pain: a preliminary investigation. Behav Res Ther (2011) 0.82
Implementing motivational interviewing in primary care: the role of provider characteristics. Transl Behav Med (2011) 0.81
Sex differences in chronic pain management practices for patients receiving opioids from the Veterans Health Administration. Pain Med (2014) 0.81
Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study. J Subst Abuse Treat (2007) 0.81
Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors. Drug Alcohol Depend (2011) 0.81
The impact of posttraumatic stress disorder on cannabis quit success. Am J Drug Alcohol Abuse (2015) 0.80
Association of Care Practices with Suicide Attempts in US Veterans Prescribed Opioid Medications for Chronic Pain Management. J Gen Intern Med (2015) 0.80
Opioid use in primary care: asking the right questions. Curr Pain Headache Rep (2011) 0.79
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA. Mil Med (2012) 0.79
Practical considerations to guide development of access controls and decision support for genetic information in electronic medical records. BMC Health Serv Res (2011) 0.79
Brief report: Validation of a quantitative HIV risk prediction tool using a national HIV testing cohort. J Acquir Immune Defic Syndr (2015) 0.79
Elevated BMI and illicit drug use are associated with decreased ability to inhibit prepotent behaviors. Addict Behav (2011) 0.79
Opioid use patterns and association with pain severity and mental health functioning in chronic pain patients. Pain Med (2012) 0.78
Quality of Life after Face Transplantation: Outcomes, Assessment Tools, and Future Directions. Plast Reconstr Surg (2017) 0.78
Differential associations between perceived and objective measurement of distress tolerance in relation to antiretroviral treatment adherence and response among HIV-positive individuals. Behav Ther (2013) 0.77
Patient-centered mental health care for female veterans. Psychiatr Serv (2014) 0.77
Behavioral medicine perspectives on the design of health information technology to improve decision-making, guideline adherence, and care coordination in chronic pain management. Transl Behav Med (2011) 0.77
Prevalence and nature of criminal offending in a national sample of veterans in VA substance use treatment prior to the Operation Enduring Freedom/Operation Iraqi Freedom conflicts. Psychol Serv (2012) 0.76
Adulthood animal abuse among women court-referred to batterer intervention programs. J Interpers Violence (2012) 0.75
Problematic alcohol use among individuals with HIV: relations with everyday memory functioning and HIV symptom severity. AIDS Behav (2014) 0.75
Witnessed versus unwitnessed random urine tests in the treatment of opioid dependence. Am J Addict (2013) 0.75
Program characteristics associated with testing for HIV and hepatitis C in veterans substance use disorder clinics. Psychiatr Serv (2010) 0.75
Datapoints: false starts in psychotherapy for substance use disorders and PTSD in the VHA. Psychiatr Serv (2013) 0.75
Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program. J Am Pharm Assoc (2003) (2017) 0.75